Clinical Trials Logo
  1. Home
  2. Necrotising Enterocolitis
  3. NCT01287507

Lactoferrin Prophylaxis in VLBW and Regulator T-cells

Very Low Birth Weight Infants Clinical Trial

Official title:
Oral Lactoferrin Prophylaxis to Prevent Sepsis and Necrotising Enterocolitis of Very Low Birth Weight Neonates in Neonatal Intensive Care Unit and Effect on T-regulatory Cells.

Clinical Trial Summary

The aim of the study is to evaluate whether oral administration of 200 mg/day lactoferrin (LF) to very low birth weight infants reduces late onset sepsis and necrotising enterocolitis and the effect of LF on regulatory T cells.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver), Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01287507
Study type Interventional
Source Ankara University
Contact
Status Completed
Phase N/A
Start date December 2009
Completion date December 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00033917 - Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial Phase 3
Completed NCT02741934 - Cognitive and Behavioral Outcomes of School-aged Children Who Were Born Preterm N/A
Withdrawn NCT00470743 - Comparing Ibuprofen And Indomethacin For The Treatment Of The Patent Ductus Arteriosus in Very Premature Babies Phase 4
Completed NCT02415530 - Early Family Based Intervention in Preterm Infants N/A
Completed NCT01531192 - Comparison of Lactobacillus Reuteri and Nystatin Prophylaxis on Candida Colonization and Infection in Very Low Birth Weight Infants Phase 4
Withdrawn NCT03858816 - Efficacy of Multiple Strain Probiotics Reduces the Neurobehavioral Disorder in Premature Very Low Birth Weight Infants N/A
Terminated NCT01434849 - Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial) Phase 1
Recruiting NCT03876704 - Effects of Fat-soluble Vitamins Supplementation on Common Complications and Neural Development in Very Low Birth Weight Infants Phase 3
Completed NCT01443091 - Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants N/A
Completed NCT02383264 - Splanchnic Oxygenation After the First Enteral Feed in Preterm Infants: Prediction of Feeding Tolerance. N/A
Completed NCT01531179 - Lactobacillus Reuteri for Prevention of Necrotizing Enterocolitis in Very Low-birth Weight Infants Phase 3
Recruiting NCT01315821 - Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants Phase 3
Withdrawn NCT00425581 - N-Terminal Pro-B-Type Natriuretic Peptide and Troponin Levels as Markers of Hemodynamic Stability in Very Low Birth Weight Infants During the First Days of Life N/A
Recruiting NCT02731092 - Safety and Tolerability of Lactoferrin in Very Low Birth Weight Infants Phase 1
Terminated NCT02337088 - Delayed Cord Clamping in Very Low Birth Weight Infants N/A